Ttk Health Care Q2 Results
- BSE: 507747
- NSE: TTKHLTCARE
- ISIN: INE910C01018
- Sector: Biotechnology & Drugs
BSE
1,329.30
-27.85 (-2.05%)
-27.85 (-2.05%)Volume82.00
Updated: Mon 7 Jul, 2025 | 14:35:41
NSE
1,325.00-32.80 (-2.42%)
-32.80 (-2.42%)Volume4.07 K
Updated: Mon 7 Jul, 2025 | 15:29:50
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Ttk Health Care Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 24 | QoQ Comp |
|---|---|---|---|
| Total Operating Expense | 192.26 | 203.05 | -5.31% |
| Depreciation/ Amortization | 2.00 | 2.05 | -2.28% |
| Operating Income | 6.22 | 4.86 | 28.18% |
| Net Income | 17.20 | 31.58 | -45.52% |
| Other Operating Expenses Total | 62.69 | 69.10 | -9.28% |
| Net Income Before Taxes | 23.19 | 40.79 | -43.16% |
| Total Revenue | 198.49 | 207.90 | -4.53% |
| Selling/ General/ Admin Expenses Total | 37.72 | 38.36 | -1.67% |
| Diluted Normalized EPS | 12.17 | 11.52 | 5.66% |